G6PDH, GLUCOSE-6-PHOSHATE DEHYDROGENASE

Glucose-6-phosphate Dehydrogenase (erythrocytic), Screening

POINTE SCIENTIFIC, INC.

The following data is part of a premarket notification filed by Pointe Scientific, Inc. with the FDA for G6pdh, Glucose-6-phoshate Dehydrogenase.

Pre-market Notification Details

Device IDK024006
510k NumberK024006
Device Name:G6PDH, GLUCOSE-6-PHOSHATE DEHYDROGENASE
ClassificationGlucose-6-phosphate Dehydrogenase (erythrocytic), Screening
Applicant POINTE SCIENTIFIC, INC. 1025 JOHN A. PAPALAS DR. Lincoln Park,  MI  48146
ContactRon Jamison
CorrespondentRon Jamison
POINTE SCIENTIFIC, INC. 1025 JOHN A. PAPALAS DR. Lincoln Park,  MI  48146
Product CodeJBF  
CFR Regulation Number864.7360 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2002-12-04
Decision Date2003-03-31

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00811727015679 K024006 000
00811727014139 K024006 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.